Share the Science: Dr. Julie Allickson, Phd -Clinical translation of perinatal cells in an academic facility

UPDATE:  RECORDING NOW AVAILABLE

​Save the Cord Foundation and WellSky are proud to welcome Dr. Julie Allickson, PhD, Director of the Regenerative Medicine Clinical Center at Wake Forest for our next edition of Share the Science on Tuesday, May 21st, 2019. 

​Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field.  As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here.

Click here to watch recording of Share the Science featuring Dr. Julie Allickson, PhD

Perinatal Stem Cells: The Future in Regenerative Medicine

​Perinatal cells offer a promising opportunity for a wide range of regenerative medicine applications because of their unique immune modulatory properties, rather than their differentiation ability. As the director of one the most prestigious centers for regenerative medicine, Dr. Allickson is in a unique position to discuss the future of perinatal stem cells as a resource in the growing field of regenerative medicine. In her presentation, Dr. Allickson will provide information on clinically translating perinatal cells in an academic facility. She will detail the steps in clinical translation of cell therapy products, review an accelerated model of translation in an academic environment and discuss the assessment of perinatal tissues and cell in pre-clinical studies. 
​

SHARE THE SCIENCE
with
Dr. Julie ALLICKSON, Ph.D.

Director of the Regenerative Medicine Clinical Center
Wake Forest University School of Medicine

"Clinical Translation of Perinatal Cells in an Academic Facility"

Free webinar.  Open to the public.
​
Tuesday, May 21st, 2019 - 12pm Central Daylight Time

RECORDING AVAILABLE - WATCH NOW

---

About the speaker

​Dr. Julie Allickson, Ph.D.

With 30 years experience in clinical translation of cellular therapies and regenerative medicine products, Dr. Allickson is a scientist leader experienced in delivering innovation, driving milestones, strategic planning, program management, and regulation. She has a doctorate in health sciences-clinical immunology, along with a master's degree in medical laboratory sciences. In addition, Dr. Allickson has extensive experience as an executive officer with a publicly traded company building services for cellular banking including global licensure of technology.

At the Wake Forest Institute for Regenerative Medicine, she heads the clinical translation team, streamlining development to create a robust pipeline of products in development and early-phase clinical trials, including cell therapy, gene therapy, tissue-engineered organs and tissues, bio-materials and devices.  An experienced scientist, Dr. Allickson is responsible for  delivering innovation, driving milestones while maintaining sensitivity to financial considerations. As the lead for the research and development of tissue/cellular products for service enhancement or commercialization, Dr. Allickson has extensive experience in tissue/cellular procurement, processing, tissue engineering, cryopreservation, cellular selection/separation, expansion, tissue/cell culture, quality systems compliance, internal/external inspections and transferring technology. 

---

We wish to thank Dr. Allickson for volunteering her time to speak on
Share the Science and sharing her valuable insight on the
​perinatal stem cells and regenerative medicine.
​
We also wish to also thank our generous sponsor and partner for this event,
WellSky Health, who continue to support cord blood
education through our “Share the Science” series.